What's new

RSS
Date Content
18/02/2019 Periodic safety update single assessment: Nortriptyline: List of nationally authorised medicinal products - PSUSA/00002192/201803
18/02/2019 Periodic safety update single assessment: Pelargonium sidoides dc and/or pelargonium reniforme curt. / radix: List of nationally authorised medicinal products - PSUSA/00002329/201806
18/02/2019 Periodic safety update single assessment: Pholcodine / biclotymol / chlorphenamine maleate : List of nationally authorised medicinal products - PSUSA/00010437201804
18/02/2019 Periodic safety update single assessment: Nortriptyline: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementatio - PSUSA/00002192/201803
18/02/2019 Minutes: Minutes of the COMP meeting 6-8 November 2018
18/02/2019 Agenda: Agenda - COMP agenda of the 19-21 February 2019 meeting
18/02/2019 Human medicines European public assessment report (EPAR): Rituzena (previously Tuxella), rituximab, Lymphoma, Non-Hodgkin, Microscopic Polyangiitis, Leukemia, Lymphocytic, Chronic, B-Cell, Wegener Granulomatosis, 13/07/2017, Additional monitoring, Biosimilar, 7, Authorised (updated)
18/02/2019 Human medicines European public assessment report (EPAR): Sovaldi, Sofosbuvir, Hepatitis C, Chronic, 16/01/2014, Additional monitoring, 16, Authorised (updated)
18/02/2019 Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine, tenofovir disoproxil phosphate, HIV Infections, 09/11/2016, Generic, 2, Authorised (updated)
18/02/2019 Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Carcinoma, Non-Small-Cell Lung, 22/11/2018, Additional monitoring, 1, Authorised (updated)